Anti-inflammatory function of tiotropium mediated by suppression of acetylcholine-induced release of chemotactic activity

F. Bühling, N. Lieder, A. Reisenauer, T. Welte (Magdeburg, Germany)

Source: Annual Congress 2004 - COPD and lung cancer: genetics and pathogenesis
Session: COPD and lung cancer: genetics and pathogenesis
Session type: Thematic Poster Session
Number: 2024
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Bühling, N. Lieder, A. Reisenauer, T. Welte (Magdeburg, Germany). Anti-inflammatory function of tiotropium mediated by suppression of acetylcholine-induced release of chemotactic activity. Eur Respir J 2004; 24: Suppl. 48, 2024

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mechanisms of acetylcholine-induced release of proinflammatory extracellular vesicles by endothelial cells and inhibitory effects of tiotropium
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019


The PDE4-inhibitors roflumilast and rolipram modulate fibroblast collagen-gel contraction and chemotaxis mediated by autocrine PGE2 synthesis induced by TGF-β1
Source: Eur Respir J 2005; 26: Suppl. 49, 214s
Year: 2005

Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor
Source: Eur Respir J 2004; 24: Suppl. 48, 345s
Year: 2004

Inhibitory effect of statins on fibrogenic mediator production from lung cells
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Cilomilast, a second generation phosphodiestease 4 inhibitor, in combination with PGE2 attenuates fMLP, IL-8 and cigarette smoke-induced effects on the mechanical and functional properties of neutrophils
Source: Eur Respir J 2001; 18: Suppl. 33, 161s
Year: 2001

Effects of glucocorticosteroids and antimicrobial drugs on inhibition of IL-1β- and PDBu-induced IL-8 release in the presence of pyocyanin in bronchial epithelial cell line
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005

Tiotropium inhibits acetylcholine-induced generation of proinflammatory microparticles by human pulmonary epithelial cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007


Anti-inflammatory activity of doxofylline and theophylline in LPS-induced lung inflammation
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Synergistic inhibition of oxidative burst in human eosinophils by combination treatment with formoterol and budesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001

Inhibition of chloride channel activity by BMP-2 in lung fibroblasts opposes profibrotic action of endothelin-1
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010

Inhibition of eosinophil migration by montelukast, a cysteinyl leukotriene receptor antagonist, through down regulation of plasmin activity
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004

Roflumilast potently inhibits CXCL1 mediated neutrophil migration in COPD patients
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011

Synergistic inhibition of salmeterol with fluticasone propionate or rolipram on stimulated eosinophil binding of β2-integrin to ICAM-1 and cytosolic gIV-phospholipase A2 activation
Source: Eur Respir J 2003; 22: Suppl. 45, 455s
Year: 2003

Formoterol is more potent and more effective than salmeterol in the inhibition of oxidative burst in human eosinophils
Source: Eur Respir J 2001; 18: Suppl. 33, 49s
Year: 2001

The effect of nicotine on COX-dependent airway relaxation and inflammatory mediator expression
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Rapid inhibitory effects of budesonide and formoterol on bradykinin-induced Ca2+ mobilization in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003

Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002